Foundation Science

Formulation Development - Comprehensive Development Solutions

At Lipoedge, we provide comprehensive formulation development support, encompassing the entire journey from raw material selection to commercial-scale manufacturing. Our integrated approach combines sourcing pharmaceutical-grade materials, advanced liposomal engineering, seamless technology transfer, and regulatory-compliant documentation.

Dossier Support

Multi-jurisdictional compliance: Preparation of DMF, CTD, ACTD, FSSAI, and CDSCO-compliant dossiers that address jurisdiction-specific requirements for seamless approval.
Analytical method validation: ICH-compliant protocols including particle size analysis, encapsulation efficiency, stability indicating parameters supporting regulatory acceptance.
Scientific visual verification: High-resolution electron microscopy and Franz diffusion studies providing empirical evidence of structural integrity and delivery performance.
Submission-ready documentation: Complete technical packages including MFR, BMR, specifications, and validation protocols, ensuring audit readiness and compliance assurance.

Technology Transfer Support

Process parameter optimisation: Exact translation of laboratory conditions to industrial scale, maintaining particle size distribution and release profile integrity.
Equipment compatibility assessment: Comprehensive evaluation and modification of existing manufacturing infrastructure, ensuring nanotechnology processing capability.
Batch consistency protocols: Implementation of Critical Quality Attributes ensuring the thousandth batch remains identical to the first laboratory-validated formulation.
Manufacturing team training: Comprehensive knowledge transfer enabling production teams to maintain scientific potency throughout commercial manufacturing.

Formulation Support

Precision particle engineering: Sub-100nm vesicle formation through high-speed homogenization and sonication, achieving water-like clarity with enhanced bioavailability.
Complex active stabilisation: Mastery of conflicting ingredient integration, including acids, antioxidants, and growth factors within single transparent delivery systems.
Quality by design implementation: Systematic optimisation of Critical Process Parameters and Quality Attributes, ensuring reproducible manufacturing excellence.
Bioavailability enhancement: Advanced delivery mechanisms achieving >95% dermal penetration with minimal surface residue through engineered partitioning technology.

Raw Material Support

High-purity API sourcing: Pharmaceutical-grade active ingredients with full pharmacopeial compliance (USP, BP, EP, IP), ensuring superior formulation integrity.
Advanced phospholipid qualification: Specialised lecithin selection with enhanced phosphatidylcholine and phosphatidylethanolamine content for optimal vesicle formation and stability.
Global regulatory screening: Comprehensive material assessment across FSSAI, CDSCO, FDA, and EMA regulatory frameworks, ensuring unrestricted international market access.
Impurity risk management: Scientific evaluation of elemental impurities, heavy metals, residual solvents ensuring toxicological safety and regulatory acceptance.